246 related articles for article (PubMed ID: 15288472)
1. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
[TBL] [Abstract][Full Text] [Related]
2. The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.
Reif S; Weis B; Aeed H; Gana-Weis M; Zaidel L; Avni Y; Romanelli RG; Pinzani M; Kloog Y; Bruck R
J Hepatol; 1999 Dec; 31(6):1053-61. PubMed ID: 10604579
[TBL] [Abstract][Full Text] [Related]
3. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
[TBL] [Abstract][Full Text] [Related]
5. Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats.
Moreira E; Fontana L; Periago JL; Sanchéz De Medina F; Gil A
Hepatology; 1995 Jan; 21(1):199-206. PubMed ID: 7806155
[TBL] [Abstract][Full Text] [Related]
6. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J
Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism.
Oren R; Dotan I; Papa M; Marravi Y; Aeed H; Barg J; Zeidel L; Bruck R; Halpern Z
Hepatology; 1996 Aug; 24(2):419-23. PubMed ID: 8690414
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide.
Hori Y; Sato S; Yamate J; Kurasaki M; Nishihira J; Hosokawa T; Fujita H; Saito T
Eur J Histochem; 2003; 47(4):317-24. PubMed ID: 14706927
[TBL] [Abstract][Full Text] [Related]
9. Alterations to hepatic microcirculation in thioacetamide-induced cirrhotic livers of rats.
Nakata M; Nakamura K; Koda Y; Kaminou T; Ogami M; Yamada R
Osaka City Med J; 2002 Jun; 48(1):1-8. PubMed ID: 12375692
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen, plasma fibronectin, and liver regeneration rate after seventy percent hepatectomy in normal and cirrhotic rats.
Chijiiwa K; Nakano K; Kameoka N; Nagai E; Tanaka M
Surgery; 1994 Sep; 116(3):544-9. PubMed ID: 7915857
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental cirrhosis in rats by HD-03.
Mitra SK; Udupa UV; Sheshadri SJ; Venkataranganna MV; Gopumadhavan S; Anturlikar SD
Acta Pharmacol Sin; 2000 Sep; 21(9):777-81. PubMed ID: 11501156
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation and extracellular matrix in normal and cirrhotic rat livers following 70% hepatectomy.
Andiran F; Kilinç K; Renda N; Ayhan A; Tanyel FC
Hepatogastroenterology; 2003; 50(51):805-8. PubMed ID: 12828089
[TBL] [Abstract][Full Text] [Related]
14. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat.
Iimuro Y; Nishio T; Morimoto T; Nitta T; Stefanovic B; Choi SK; Brenner DA; Yamaoka Y
Gastroenterology; 2003 Feb; 124(2):445-58. PubMed ID: 12557150
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis.
Buko V; Lukivskaya O; Nikitin V; Kuryan A; Dargel R
Exp Toxicol Pathol; 1997 Feb; 49(1-2):141-6. PubMed ID: 9085089
[TBL] [Abstract][Full Text] [Related]
16. Experimental thioacetamide-induced cirrhosis of the liver.
Muñoz Torres E; Paz Bouza JI; López Bravo A; Abad Hernández MM; Carrascal Marino E
Histol Histopathol; 1991 Jan; 6(1):95-100. PubMed ID: 1806061
[TBL] [Abstract][Full Text] [Related]
17. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model.
Shohami E; Yatsiv I; Alexandrovich A; Haklai R; Elad-Sfadia G; Grossman R; Biegon A; Kloog Y
J Cereb Blood Flow Metab; 2003 Jun; 23(6):728-38. PubMed ID: 12796721
[TBL] [Abstract][Full Text] [Related]
18. [Modifications of the enzymatic content and morphology of the exocrine pancreas of rats with experimental hepatic cirrhosis induced by thioacetamide].
Santamaría Gil ME; de Andrés Loste MS; Fernández Alonso MC; González Fernández E; Blanco Varela FJ; Coca García MC; Caro-Patón Gómez A
An Med Interna; 1991 Dec; 8(12):601-4. PubMed ID: 1723629
[TBL] [Abstract][Full Text] [Related]
19. Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis.
Nakajima M; Iwata K; Yamamoto T; Funae Y; Yoshida T; Kuroiwa Y
Drug Metab Dispos; 1998 Jan; 26(1):36-41. PubMed ID: 9443850
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of bile flow and inhibition of biliary secretion of taurocholate and leukotriene C4 in thioacetamide-induced liver fibrosis.
Müller D; Dietze E; Dargel R; Krell H
Z Gastroenterol; 1993 Feb; 31 Suppl 2():16-9. PubMed ID: 7483705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
